Dr. Potter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton St SE
Minneapolis, MN 55455Phone+1 612-273-8383Fax+1 612-624-1443
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1993
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1992
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1986 - 1988
Johns Hopkins University School of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 1988 - Present
MN State Medical License 2006 - 2025
IN State Medical License 2000 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer Start of enrollment: 2010 May 26
Publications & Presentations
PubMed
- The partnership between statisticians and the Institutional Animal Care and Use Committee (IACUC).David Potter, Thomas Bradstreet, Davit Sargsyan, Xiao Tan, Vinicius Bonato
Pharmaceutical Statistics. 2024-06-11 - Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time.Adnan Shaaban, Ashley Petersen, Heather Beckwith, Natalia Florea, David A Potter
Cardio-Oncology. 2024-05-01 - Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.Haiyun Wang, Douglas Yee, David Potter, Patricia Jewett, Christina Yau
Breast Cancer Research and Treatment. 2024-04-01
Grant Support
- Potentiation of immune checkpoint blockade by inhibition of epoxyeicosatrienoic acid driven tumor respirationDOD2019–2022
- Epoxygenase Mechanisms Of Breast Cancer ProgressionNational Cancer Institute2007–2008
- Epoxygenease Mechanisms Of Breast Cancer ProgressionNational Cancer Institute2006
- Epoxygenase Mechanisms Of Breast Cancer ProgressionNational Cancer Institute2005
- Functional Analysis Of Transcription Factors In HIV-1National Cancer Institute1993–1996
- Functional Analysis Of Transcription Factors In HIV-1National Cancer Institute1991
- An Inducible Hepatic Polymerase II Transcription SystemNational Institute Of General Medical Sciences1985
Research History
- Associate ProfessorRoles of Cytochrome P450 Arachidonic Acid Oxidases in Breast Cancer Progression
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
